ATON
Price
$5.77
Change
-$0.48 (-7.68%)
Updated
Sep 26 closing price
Capitalization
34.76M
NBY
Price
$2.19
Change
+$0.05 (+2.34%)
Updated
Sep 26 closing price
Capitalization
13.15M
Interact to see
Advertisement

ATON vs NBY

Header iconATON vs NBY Comparison
Open Charts ATON vs NBYBanner chart's image
AlphaTON Capital
Price$5.77
Change-$0.48 (-7.68%)
Volume$38.86K
Capitalization34.76M
NovaBay Pharmaceuticals
Price$2.19
Change+$0.05 (+2.34%)
Volume$196.98K
Capitalization13.15M
ATON vs NBY Comparison Chart in %
Loading...
ATON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATON vs. NBY commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATON is a Hold and NBY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ATON: $5.77 vs. NBY: $2.19)
Brand notoriety: ATON and NBY are both not notable
ATON represents the Investment Managers, while NBY is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATON: 52% vs. NBY: 2%
Market capitalization -- ATON: $34.76M vs. NBY: $13.15M
ATON [@Investment Managers] is valued at $34.76M. NBY’s [@Biotechnology] market capitalization is $13.15M. The market cap for tickers in the [@Investment Managers] industry ranges from $179.08B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Investment Managers] industry is $7.43B. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATON’s FA Score shows that 0 FA rating(s) are green whileNBY’s FA Score has 3 green FA rating(s).

  • ATON’s FA Score: 0 green, 5 red.
  • NBY’s FA Score: 3 green, 2 red.
According to our system of comparison, NBY is a better buy in the long-term than ATON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATON’s TA Score shows that 5 TA indicator(s) are bullish while NBY’s TA Score has 5 bullish TA indicator(s).

  • ATON’s TA Score: 5 bullish, 5 bearish.
  • NBY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ATON and NBY are a good buy in the short-term.

Price Growth

ATON (@Investment Managers) experienced а -4.94% price change this week, while NBY (@Biotechnology) price change was +20.33% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was -1.95%. For the same industry, the average monthly price growth was +2.07%, and the average quarterly price growth was +39.07%.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Industries' Descriptions

@Investment Managers (-1.95% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATON($34.8M) has a higher market cap than NBY($13.2M). NBY YTD gains are higher at: 264.393 vs. ATON (11.605).
ATONNBYATON / NBY
Capitalization34.8M13.2M264%
EBITDAN/A-7.05M-
Gain YTD11.605264.3934%
P/E RatioN/A0.95-
RevenueN/A9.78M-
Total CashN/A5.34M-
Total DebtN/A1.04M-
FUNDAMENTALS RATINGS
ATON vs NBY: Fundamental Ratings
ATON
NBY
OUTLOOK RATING
1..100
7747
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10012
PRICE GROWTH RATING
1..100
6534
P/E GROWTH RATING
1..100
861
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NBY's Valuation (33) in the Biotechnology industry is somewhat better than the same rating for ATON (92) in the null industry. This means that NBY’s stock grew somewhat faster than ATON’s over the last 12 months.

NBY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATON (100) in the null industry. This means that NBY’s stock grew similarly to ATON’s over the last 12 months.

NBY's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for ATON (100) in the null industry. This means that NBY’s stock grew significantly faster than ATON’s over the last 12 months.

NBY's Price Growth Rating (34) in the Biotechnology industry is in the same range as ATON (65) in the null industry. This means that NBY’s stock grew similarly to ATON’s over the last 12 months.

NBY's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for ATON (86) in the null industry. This means that NBY’s stock grew significantly faster than ATON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATONNBY
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 20 days ago
86%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAMS28.502.21
+8.41%
NewAmsterdam Pharma Company NV
EML24.580.21
+0.86%
Eastern Company
IP45.32N/A
N/A
International Paper Co
MYGN7.70-0.06
-0.77%
Myriad Genetics
BNZI2.77-0.25
-8.28%
Banzai International Inc

ATON and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATON has been loosely correlated with NBY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ATON jumps, then NBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATON
1D Price
Change %
ATON100%
-7.68%
NBY - ATON
46%
Loosely correlated
+2.34%
NEVPF - ATON
45%
Loosely correlated
N/A
CORT - ATON
29%
Poorly correlated
+1.38%
AMGXF - ATON
28%
Poorly correlated
N/A
DYAI - ATON
27%
Poorly correlated
-5.98%
More

NBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBY has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NBY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBY
1D Price
Change %
NBY100%
+2.34%
CDTX - NBY
93%
Closely correlated
+6.77%
NCNA - NBY
93%
Closely correlated
+0.75%
TAOX - NBY
91%
Closely correlated
+6.95%
RNAC - NBY
91%
Closely correlated
-2.11%
AGEN - NBY
90%
Closely correlated
+1.28%
More